Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I

NCT01501487 is registered in ClinicalTrials.gov with Agendia as lead sponsor.

NCT NCT01501487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01501487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I
Lead sponsor
Agendia
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2011
Completion date
June 30, 2017
Enrollment
226 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer